Britain's competition regulator has fined more than 10 drug firms a record combined 260 million pounds ($360 million) for overcharging the National Health Service (NHS) for a steroid which rose from 70p to 88 pounds a pack in under eight years.
(Reuters) -Europe's drug regulator on Wednesday refrained from making any recommendations on mixing schedules of COVID-19 vaccines with doses from different manufacturers, saying it was too early to confirm if and when an additional booster shot would be needed.
Europe's drug regulator has found a possible link between very rare heart inflammation and COVID-19 vaccines from Pfizer-BioNTech and Moderna, it said on Friday, stressing that the benefits of the shots outweighed any risks.
British online betting firm 888 on Wednesday signalled that a reopening of outdoor venues after coronavirus lockdowns was hurting daily revenues in the country, as people spend less time indoors and online.
(Reuters) -British online betting firm 888 on Wednesday signalled that a reopening of outdoor venues after coronavirus lockdowns was hurting daily revenues in the country, as people spend less time indoors and online.
* UK avg. daily sales 20% lower since May 17 vs earlier in
(Reuters) -Playtech shareholder Gopher Investments on Tuesday made a fresh case for its offer to buy the gambling software maker's financial trading division, weeks after Playtech agreed to sell the business to another group.
(Reuters) -Australia's Ramsay Health Care has raised its offer to buy British peer Spire Healthcare to about 1.04 billion pounds ($1.44 billion), the hospital operators said on Monday, after reports of some investor opposition to a deal agreed earlier.
(Reuters) -GSK on Friday rejected Elliott's demands that the British company change its board and sell its consumer healthcare arm after separating it from its pharma business, a day after strongly worded proposals from the activist investor.